Search research articles
Contact Us
Filters
Showing results (321-330 of 339) with videos related to
Page
of 34
Sort By:
The Lancet. Haematology
|
January 29, 2021
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study
Lisa Pleyer, Michael Leisch, Alexandra Kourakli, et al.
Leukemia
|
August 5, 2024
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study
Elena Crisà, Elvira Mora, Ulrich Germing, et al.
Blood Cancer Journal
|
April 8, 2025
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients
Christina Rautenberg, Jan Moritz Middeke, Christoph Röllig, et al.
Blood Cancer Journal
|
October 5, 2021
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Blood Cancer Journal
|
July 15, 2025
Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency
Lili Kotmayer, Emilia J Kozyra, Guolian Kang, et al.
The New England Journal of Medicine
|
January 9, 2020
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
Pierre Fenaux, Uwe Platzbecker, Ghulam J Mufti, et al.
Leukemia
|
April 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?
Maria Julia Montoro, Pamela Acha, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
Luca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Leukemia & Lymphoma
|
August 25, 2012
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group
Arjan A van de Loosdrecht, Robin Ireland, Wolfgang Kern, et al.
Page
of 34
Search research articles
Search
Showing results (321-330 of 339) with videos related to
Sort By:
Page
of 34
The Lancet. Haematology
|
January 29, 2021
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study
Lisa Pleyer, Michael Leisch, Alexandra Kourakli, et al.
Leukemia
|
August 5, 2024
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study
Elena Crisà, Elvira Mora, Ulrich Germing, et al.
Blood Cancer Journal
|
April 8, 2025
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients
Christina Rautenberg, Jan Moritz Middeke, Christoph Röllig, et al.
Blood Cancer Journal
|
October 5, 2021
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Blood Cancer Journal
|
July 15, 2025
Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency
Lili Kotmayer, Emilia J Kozyra, Guolian Kang, et al.
The New England Journal of Medicine
|
January 9, 2020
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
Pierre Fenaux, Uwe Platzbecker, Ghulam J Mufti, et al.
Leukemia
|
April 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?
Maria Julia Montoro, Pamela Acha, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
Luca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Leukemia & Lymphoma
|
August 25, 2012
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group
Arjan A van de Loosdrecht, Robin Ireland, Wolfgang Kern, et al.
Page
of 34